Systemic inflammation present in patients undergoing CABG without extracorporeal circulation

被引:137
作者
Fransen, E
Maessen, J
Dentener, M
Senden, N
Geskes, G
Buurman, W
机构
[1] Univ Hosp Maastricht, Dept Cardiopulm Surg, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Pulmonol, NL-6202 AZ Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Surg, NL-6202 AZ Maastricht, Netherlands
关键词
acute phase response; cardiopulmonary bypass; noncardiopulmonary bypass CABG; polymorphonuclear neutrophils activation;
D O I
10.1378/chest.113.5.1290
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: This study was conducted to evaluate to what extent the cardiopulmonary bypass (CPB) procedure in patients undergoing coronary artery bypass grafting (CABG) contributes to the systemic inflammatory response. Therefore, we measured bactericidal permeability increasing protein (BPI) as an indicator of neutrophil activation, interleukin 6 as inducer of the acute phase response, and lipopolysaccharide binding protein and C-reactive protein as parameters of the acute phase response in patients undergoing CABG either with or without the use of CPB, Design: Prospective study. Setting: Cardiopulmonary surgery department in a university hospital, Patients: Sixteen patients undergoing elective CABG were included. Eight patients underwent surgery with CPB, and eight patients underwent surgery without CPB (non-CPB), Interventions: In the CPB group, blood samples were taken upon induction of anesthesia, at the start of aortic cross-clamping, at aortic unclamping, and 0.5, 4, 8, and 18 h thereafter. In the non-CPB group, blood samples were taken upon induction of anesthesia, and 0.5, 4, 8, and 18 h after completion of the bypass graft anastomoses. Measurements and results: BPI release from neutrophil granules markedly increased during surgery in CPB patients but not in non-CPB patients. The increase in acute phase reactants, however, was the same in both patient groups. Conclusions: These data indicate that the acute phase response in CABG patients, which has historically been ascribed to the CPB procedure, is predominantly caused by the surgical procedure per se. Early neutrophil activation, however, is seen only when extracorporeal circulation is used.
引用
收藏
页码:1290 / 1295
页数:6
相关论文
共 31 条
  • [1] ANDERSEN LW, 1987, J THORAC CARDIOV SUR, V93, P115
  • [2] Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits - A clinical pilot study
    Bouma, M
    Maessen, J
    Weerwind, P
    Dentener, M
    Fransen, E
    deJong, D
    Buurman, W
    [J]. CHEST, 1997, 111 (03) : 577 - 583
  • [3] BOYDEN A, 1947, J IMMUNOL, V57, P211
  • [4] INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
    BUTLER, J
    ROCKER, GM
    WESTABY, S
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (02) : 552 - 559
  • [5] Systemic inflammatory response syndrome after cardiac operations
    Cremer, J
    Martin, M
    Redl, H
    Bahrami, S
    Abraham, C
    Graeter, T
    Haverich, A
    Schlag, G
    Borst, HG
    [J]. ANNALS OF THORACIC SURGERY, 1996, 61 (06) : 1714 - 1720
  • [6] RESPONSE OF SERUM INTERLEUKIN-6 IN PATIENTS UNDERGOING ELECTIVE SURGERY OF VARYING SEVERITY
    CRUICKSHANK, AM
    FRASER, WD
    BURNS, HJG
    VANDAMME, J
    SHENKIN, A
    [J]. CLINICAL SCIENCE, 1990, 79 (02) : 161 - 165
  • [7] Bactericidal permeability-increasing protein release in whole blood ex vivo: Strong induction by lipopolysaccharide and tumor necrosis factor-alpha
    Dentener, MA
    Francot, GJM
    Hiemstra, PS
    Tool, ATJ
    Verhoeven, AJ
    Vandenabeele, P
    Buurman, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) : 108 - 117
  • [8] PRESENCE OF BACTERICIDAL PERMEABILITY-INCREASING PROTEIN IN DISEASE - DETECTION BY ELISA
    DENTENER, MA
    FRANCOT, GJM
    SMIT, FT
    FROON, AHM
    PENNINGS, HJ
    WOUTERS, EFM
    BUURMAN, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 739 - 743
  • [9] DENTENER MA, 1993, J IMMUNOL, V150, P2885
  • [10] DENTENER MA, 1993, J IMMUNOL, V151, P4258